| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:01:37 UTC |
|---|
| Update Date | 2021-09-14 15:39:00 UTC |
|---|
| HMDB ID | HMDB0014256 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Tafluprost free acid |
|---|
| Description | Tafluprost free acid belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. Based on a literature review a small amount of articles have been published on Tafluprost free acid. |
|---|
| Structure | OC1CC(O)C(\C=C\C(F)(F)COC2=CC=CC=C2)C1C\C=C/CCCC(O)=O InChI=1S/C22H28F2O5/c23-22(24,15-29-16-8-4-3-5-9-16)13-12-18-17(19(25)14-20(18)26)10-6-1-2-7-11-21(27)28/h1,3-6,8-9,12-13,17-20,25-26H,2,7,10-11,14-15H2,(H,27,28)/b6-1-,13-12+ |
|---|
| Synonyms | | Value | Source |
|---|
| (5Z)-7-{2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate | HMDB |
|
|---|
| Chemical Formula | C22H28F2O5 |
|---|
| Average Molecular Weight | 410.4515 |
|---|
| Monoisotopic Molecular Weight | 410.190480416 |
|---|
| IUPAC Name | (5Z)-7-{2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoic acid |
|---|
| Traditional Name | (5Z)-7-{2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC1CC(O)C(\C=C\C(F)(F)COC2=CC=CC=C2)C1C\C=C/CCCC(O)=O |
|---|
| InChI Identifier | InChI=1S/C22H28F2O5/c23-22(24,15-29-16-8-4-3-5-9-16)13-12-18-17(19(25)14-20(18)26)10-6-1-2-7-11-21(27)28/h1,3-6,8-9,12-13,17-20,25-26H,2,7,10-11,14-15H2,(H,27,28)/b6-1-,13-12+ |
|---|
| InChI Key | KIQXRQVVYTYYAZ-MTNCBHNASA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Eicosanoids |
|---|
| Direct Parent | Prostaglandins and related compounds |
|---|
| Alternative Parents | |
|---|
| Substituents | - Prostaglandin skeleton
- Long-chain fatty acid
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Halogenated fatty acid
- Hydroxy fatty acid
- Monocyclic benzene moiety
- Fatty acid
- Benzenoid
- Unsaturated fatty acid
- Cyclopentanol
- Cyclic alcohol
- Secondary alcohol
- Ether
- Carboxylic acid
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organohalogen compound
- Organofluoride
- Organooxygen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Alkyl halide
- Alkyl fluoride
- Organic oxygen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.04 minutes | 32390414 | | Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.59 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.6012 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.39 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2629.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 226.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 187.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 190.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 199.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 602.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 505.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 132.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1246.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 536.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1298.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 387.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 409.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 316.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 215.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Tafluprost free acid,1TMS,isomer #1 | C[Si](C)(C)OC1CC(O)C(/C=C/C(F)(F)COC2=CC=CC=C2)C1C/C=C\CCCC(=O)O | 2946.5 | Semi standard non polar | 33892256 | | Tafluprost free acid,1TMS,isomer #2 | C[Si](C)(C)OC1CC(O)C(C/C=C\CCCC(=O)O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 2938.1 | Semi standard non polar | 33892256 | | Tafluprost free acid,1TMS,isomer #3 | C[Si](C)(C)OC(=O)CCC/C=C\CC1C(O)CC(O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 2939.9 | Semi standard non polar | 33892256 | | Tafluprost free acid,2TMS,isomer #1 | C[Si](C)(C)OC1CC(O[Si](C)(C)C)C(C/C=C\CCCC(=O)O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 2921.5 | Semi standard non polar | 33892256 | | Tafluprost free acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CCC/C=C\CC1C(O[Si](C)(C)C)CC(O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 2888.1 | Semi standard non polar | 33892256 | | Tafluprost free acid,2TMS,isomer #3 | C[Si](C)(C)OC(=O)CCC/C=C\CC1C(O)CC(O[Si](C)(C)C)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 2879.4 | Semi standard non polar | 33892256 | | Tafluprost free acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CCC/C=C\CC1C(O[Si](C)(C)C)CC(O[Si](C)(C)C)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 2837.7 | Semi standard non polar | 33892256 | | Tafluprost free acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(O)C(/C=C/C(F)(F)COC2=CC=CC=C2)C1C/C=C\CCCC(=O)O | 3181.3 | Semi standard non polar | 33892256 | | Tafluprost free acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1CC(O)C(C/C=C\CCCC(=O)O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 3169.3 | Semi standard non polar | 33892256 | | Tafluprost free acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)CCC/C=C\CC1C(O)CC(O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 3197.2 | Semi standard non polar | 33892256 | | Tafluprost free acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CC(O[Si](C)(C)C(C)(C)C)C(C/C=C\CCCC(=O)O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 3339.4 | Semi standard non polar | 33892256 | | Tafluprost free acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCC/C=C\CC1C(O[Si](C)(C)C(C)(C)C)CC(O)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 3339.8 | Semi standard non polar | 33892256 | | Tafluprost free acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)CCC/C=C\CC1C(O)CC(O[Si](C)(C)C(C)(C)C)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 3332.9 | Semi standard non polar | 33892256 | | Tafluprost free acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCC/C=C\CC1C(O[Si](C)(C)C(C)(C)C)CC(O[Si](C)(C)C(C)(C)C)C1/C=C/C(F)(F)COC1=CC=CC=C1 | 3470.7 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Tafluprost free acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-014r-1219000000-8e1ec65ae01361e172d1 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tafluprost free acid GC-MS (3 TMS) - 70eV, Positive | splash10-03di-5500489000-95bafbabe02fb2fdaf57 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tafluprost free acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 10V, Positive-QTOF | splash10-002g-1029100000-204ed18144108c4fbbb2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 20V, Positive-QTOF | splash10-002e-1229000000-25077f9e4ce508bf95e3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 40V, Positive-QTOF | splash10-000b-9260000000-076c2111abf02e5ae67b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 10V, Negative-QTOF | splash10-0006-9002200000-c00792117fdb4db5e3ef | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 20V, Negative-QTOF | splash10-0006-9001000000-08fd3ce154d6769f5222 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 40V, Negative-QTOF | splash10-0006-9110000000-0e95f48713dae3d60241 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 10V, Negative-QTOF | splash10-0006-9001300000-7aec5b4ddcff3ac3f0c2 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 20V, Negative-QTOF | splash10-0006-9000000000-08485aaf085c13d5129a | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 40V, Negative-QTOF | splash10-0006-9000000000-08485aaf085c13d5129a | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 10V, Positive-QTOF | splash10-004l-0049100000-6ef9a55a21ae3bd86e51 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 20V, Positive-QTOF | splash10-00nr-2289000000-5abc56977aad023ef4d0 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tafluprost free acid 40V, Positive-QTOF | splash10-00pu-9232000000-28994a5f3f961fcc7dbc | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|